DAVITA INC. — Director's Dealing 2016

Mar 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-03-21

Reporting Person: Kogod Dennis (Pres, HCP & CEO, DVA Int.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-21	Common Stock	M	56250	$55.34	Acquired	92716	Direct
2016-03-21	Common Stock	F	42795	$72.74	Disposed	49921	Direct
2016-03-21	Common Stock	S	13455	$72.1157	Disposed	36466	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-21	Stock Appreciation Rights	$55.34	M	56250	Disposed	2017-12-18	Common Stock (56250)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	84350	Indirect

Footnotes

F1: Represents the weighted average sale price of $72.1157. The range of prices for the sale of these shares was $72.11 - $72.17, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2: The Stock Appreciation Rights were granted on 12/18/2012. 50% vested on 4/1/2015 and the remaining 50% will vest on 4/1/2016.